# Huaier Granule and Proteinuria

> **NCT07355361** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 120 (estimated)

## Conditions studied

- Proteinuria
- Breast Cancer Patients

## Interventions

- **DRUG:** Huaier Granule
- **DRUG:** Antitumor therapy
- **DRUG:** Proteinuria Management

## Key facts

- **NCT ID:** NCT07355361
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-01-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2028-06-15
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07355361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07355361, "Huaier Granule and Proteinuria". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07355361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
